BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 12858071)

  • 1. The evolving management of migraine.
    Ashkenazi A; Silberstein SD
    Curr Opin Neurol; 2003 Jun; 16(3):341-5. PubMed ID: 12858071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative aspects of triptans in treating migraine.
    Adelman JU; Lewit EJ
    Clin Cornerstone; 2001; 4(3):53-64. PubMed ID: 12739316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic migraine: a therapeutic challenge for clinicians.
    Irimia P; Carmona-Abellán M; Martínez-Vila E
    Expert Opin Emerg Drugs; 2012 Dec; 17(4):445-7. PubMed ID: 22998764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin and other new approaches to migraine therapy.
    Ashkenazi A; Silberstein SD
    Annu Rev Med; 2004; 55():505-18. PubMed ID: 14746533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two center, randomized pilot study of migraine prophylaxis comparing paradigms using pre-emptive frovatriptan or daily topiramate: research and clinical implications.
    Cady RK; Voirin J; Farmer K; Browning R; Beach ME; Tarrasch J
    Headache; 2012 May; 52(5):749-64. PubMed ID: 22188311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute management of migraine: triptans and beyond.
    Diener HC; Limmroth V
    Curr Opin Neurol; 1999 Jun; 12(3):261-7. PubMed ID: 10499171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and emerging second-generation triptans in acute migraine therapy: a comparative review.
    Deleu D; Hanssens Y
    J Clin Pharmacol; 2000 Jul; 40(7):687-700. PubMed ID: 10883409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long-term tolerability and efficacy of oral zolmitriptan (Zomig, 311C90) in the acute treatment of migraine. An international study. The International 311C90 Long-term Study Group.
    Headache; 1998 Mar; 38(3):173-83. PubMed ID: 9563207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Migraine Intervention Score - a tool to improve efficacy of triptans in acute migraine therapy: the ALADIN study.
    Göbel H; Heinze A
    Int J Clin Pract; 2011 Aug; 65(8):879-86. PubMed ID: 21762313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and tolerability of frovatriptan and dexketoprofen for the treatment of acute migraine attacks.
    Allais G; Rolando S; De Lorenzo C; Benedetto C
    Expert Rev Neurother; 2014 Aug; 14(8):867-77. PubMed ID: 25056381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine.
    Chen LC; Ashcroft DM
    Headache; 2008 Feb; 48(2):236-47. PubMed ID: 18179569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic evaluation of frovatriptan.
    Negro A; Lionetto L; Casolla B; Lala N; Simmaco M; Martelletti P
    Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1449-58. PubMed ID: 21929465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology and efficacy of eletriptan for the treatment of migraine attacks.
    Diener HC; McHarg A
    Int J Clin Pract; 2000 Dec; 54(10):670-4. PubMed ID: 11221281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study.
    Gawel M; Aschoff J; May A; Charlesworth BR;
    Headache; 2005 Jan; 45(1):7-16. PubMed ID: 15663607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacology of the serotonin receptor agonist, zolmitriptan.
    Peterlin BL; Rapoport AM
    Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):899-911. PubMed ID: 18028032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and economic comparison of frovatriptan versus other oral triptans in the treatment of acute migraine in the real-world setting.
    Guidotti M; Ravasio R
    Clin Drug Investig; 2009; 29(11):693-702. PubMed ID: 19813772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zolmitriptan nasal spray exhibits good long-term safety and tolerability in migraine: results of the INDEX trial.
    Dowson AJ; Charlesworth BR; Green J; Färkkilä M; Diener HC; Hansen SB; Gawel M;
    Headache; 2005 Jan; 45(1):17-24. PubMed ID: 15663608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
    MacGregor EA; Brandes JL; Silberstein S; Jeka S; Czapinski P; Shaw B; Pawsey S
    Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in pharmacological treatment of migraine.
    Diener HC; Limmroth V
    Expert Opin Investig Drugs; 2001 Oct; 10(10):1831-45. PubMed ID: 11772289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.
    Seeburger JL; Cady RK; Winner P; MacGregor A; Valade D; Ge Y; Zhang Y; Hustad CM; Strickler N; Schaefer E; Connor KM; Ho TW
    Headache; 2012 Jan; 52(1):57-67. PubMed ID: 22078129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.